Clinical Trials Logo

Contraception clinical trials

View clinical trials related to Contraception.

Filter by:

NCT ID: NCT03058978 Completed - Contraception Clinical Trials

Assessing Ovarian Function During Prolonged Implant Use

Start date: March 1, 2017
Phase:
Study type: Observational

The study will evaluate how the ovaries may be functioning while using the the Implanon®/Nexplanon® during the three years beyond the FDA approved duration. Ovarian function will be assessed with weekly serum progesterone levels. Participants will undergo weekly venipuncture for a total of four draws. Participants will be followed for 30 days.

NCT ID: NCT03049592 Completed - Diabetes Clinical Trials

High-risk Obstetrical Patient Intervention Utilizing the Contraceptive CHOICE Project Script

HIBISCUS
Start date: July 2016
Phase: N/A
Study type: Interventional

High-risk obstetrical patient Intervention to promote Birth Interval Spacing utilizing the Contraceptive CHOICE project script to reduce Unintended Subsequent pregnancies (HIBISCUS) is a collaborative study utilizing qualitative methods to assess the acceptability including a family planning specialist's postpartum contraception counseling during and after prenatal care among Latina obstetric women with pre-gestational diabetes. The investigators will compare the effectiveness of HIBISCUS versus usual contraceptive counseling on Long-Acting Reversible Contraception (LARC) use at 3 months postpartum.

NCT ID: NCT03034057 Completed - Contraception Clinical Trials

Sayana Press UK Self-Injection Study

Start date: August 23, 2017
Phase: Phase 4
Study type: Interventional

A one-year evaluation of Sayana Press self injection in women of reproductive age in the United Kingdom (UK).

NCT ID: NCT03031795 Completed - Contraception Clinical Trials

Oral Ketorolac for Pain Relief During IUD Insertion

Start date: July 2014
Phase: Phase 4
Study type: Interventional

Ketorolac is a non-steroidal anti-inflammatory drug (NSAID), similar to ibuprofen but it is used to treat more severe pain. Ketorolac (Trade name: Toradol) is typically used after surgical procedures. When taken orally, it should not cause sedation. The purpose of this study is to determine if oral ketorolac is effective at reducing pain during IUD placement versus a placebo tablet.

NCT ID: NCT03027531 Completed - Contraception Clinical Trials

eKISS: Electronic KIOSK Intervention for Safer-Sex

eKISS
Start date: February 1, 2012
Phase: N/A
Study type: Interventional

This study is a randomized controlled trial to test acceptability, feasibility and preliminary efficacy of an interactive computer-based intervention with individualized feedback to promote sexual health in adolescents and young adults with assessment of behavioral and biomarker outcomes.

NCT ID: NCT03019601 Completed - Contraception Clinical Trials

Enhancing Uptake of Family Planning Services by HIV-Infected Women Attending the PMTCT Program

Start date: September 2011
Phase: N/A
Study type: Interventional

A specific organized program utilizing peers in the PMTCT clinic who provide family planning information and support to HIV infected mothers was compared to providing standard family planning messages currently used in the clinic.

NCT ID: NCT02985541 Completed - Contraception Clinical Trials

Mirena Extension Trial

MET
Start date: December 22, 2016
Phase: Phase 3
Study type: Interventional

The study is performed to assess if Mirena is effective and safe as a birth control method beyond 5 years of use. Further the menstrual blood loss (in women that had Mirena inserted for the indication heavy menstrual bleeding [HMB]) and safety will be assessed.

NCT ID: NCT02969590 Completed - Contraception Clinical Trials

Regulation of Cervical Mucus Secretion

Start date: March 29, 2015
Phase: Phase 4
Study type: Interventional

The purpose of this study is to help us determine how hormones impact the production of cervical mucus which is a fluid secreted by the opening of the uterus, also called the cervix. During a normal menstrual cycle, cervical mucus changes in response to two hormones that the ovaries make: estrogen and progesterone. Many of the birth control methods women use thicken mucus and make it less likely for sperm to enter the uterus. The goal of this study is to better understand the effects estrogen and progesterone have on the cervical mucus in the body. To do this, the investigators will be using a drug that suppresses natural hormone production for 3 months. Estrogen and progesterone will be artificially replaced to better understand their effects. The investigators will also be studying the effect of a common birth control pill that may work by thickening cervical mucus. Last, the investigators will study some of the cells in the cervix that produce mucus.

NCT ID: NCT02967055 Completed - Contraception Clinical Trials

The Effect of Isotretinoin on the Etonogestrel Contraceptive Implant

Start date: February 15, 2017
Phase:
Study type: Observational

This exploratory study will fill a knowledge gap regarding the pharmacokinetic effects of isotretinoin on the etonogestrel (ENG) contraceptive implant.

NCT ID: NCT02957630 Completed - Contraception Clinical Trials

"E4/DRSP Endocrine Function, Metabolic Control and Hemostasis Study"

Start date: September 2016
Phase: Phase 1/Phase 2
Study type: Interventional

The proposed study will provide an assessment of the effect of this combination on endocrine function, metabolic control and hemostasis during 6 treatment cycles. This will be compared to the effects of two reference COCs.